Sangster's Reishi Mushroom Extract 8:1
Sangster's Reishi Mushroom Extract 8:1, NPN 80117766: natural health product licensed in Canada. Medicinal ingredients: Ganoderma lucidum.
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Ganoderma lucidum Extract : Matériel brut sec Extraction ratio : 8:1 Dry plant equivalent : 3,000 mg Potency : 35 % Polysaccharides | 375 mg | Not calculated |
Non-medicinal ingredients
Protéine de riz brun, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Capsule | 1 day |
Uses authorised in Canada
Source of/Provides antioxidants. Used in Herbal Medicine as a liver tonic. Used in Herbal Medicine as an adaptogen to help increase energy and resistance to stress (in case of mental and physical fatigue related to stress). Used in Herbal Medicine to support the immune system. Used in Traditional Chinese Medicine (TCM) to dispel phlegm, stop cough and arrest wheezing. Used in Traditional Chinese Medicine (TCM) to nourish the Heart and strengthen qi and blood to treat Heart and Spleen deficiencies that manifest in insomnia, forgetfulness, fatigue, listlessness and poor appetite. Used in Traditional Chinese Medicine (TCM) to strengthen the body and tonify qi.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Known Adverse Reactions
Stop use if hypersensitivity/allergy occurs.
- Cautions and Warnings
Consult a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Product record
- Other names
- Reishi Mushroom Extract 8:1
- Licence holder
- 1123573 BC Ltd.
- NPN or DIN-HM
- 80117766
- Status
- Active licence
- Licence date
- 7 April 2022
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
Source
Official Health Canada record, licence 80117766
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Sangster's Reishi Mushroom Extract 8:1 (1123573 BC Ltd.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80117766-sangster-s-reishi-mushroom-extract-8-1, updated 7 April 2022.